Industry Insights
The Rise and Fall of CoPath LIS: A Legacy Casualty of the Modern Lab Information System Era
July 6, 2026
At LigoLab, we recently published a white paper entitled "What To Do When Your Laboratory Information System Is Sunsetting." As one might suspect, the paper and its overarching message about the impact of the sunsetting of the CoPath laboratory information system, a leading LIS software for decades, garnered significant attention.
As the sunset of this widely known lab information system approaches, labs nationwide face the pressing need to transition to modern, cloud-compatible medical LIS solutions, creating both challenges and opportunities for lab directors and pathologists accustomed to their legacy LIS systems.
For those who will soon need to transition to new diagnostic lab software and are looking for a CoPath LIS system alternative, here are two helpful resources to kick-start that process:
Discover More: What You Need to Know Before Contracting with a Modern Laboratory Information System (LIS) Company
Discover More: Comparing LigoLab Informatics Platform with Legacy Laboratory Information System Software
Looking back at CoPath's rise and decline offers valuable insight into the evolution of laboratory information systems. It underscores how much modern LIS technology has advanced beyond the capabilities that once defined the anatomic pathology software market.
CoPath LIS: How It Became a Foundational Force in the Laboratory Information System Industry
The CoPath LIS system was built decades ago to streamline workflows and improve pathology lab management. It gained traction as a robust solution for pathology groups worldwide soon after its release. However, as anatomic pathology LIS technology rapidly evolved, CoPath's legacy infrastructure struggled to keep pace, leading to its eventual decline.
This blog post examines the history, rise, and ultimate sunset of CoPath's LIS system, and what it signifies for modern laboratories in their pursuit of LIS pathology management software that drives growth and innovation.
The Early Days of CoPath LIS
Building a Market Leader in Anatomic Pathology Software
CoPath’s laboratory information system was originally designed in the 1990s as a specialized LIS medical solution for anatomic pathology laboratories. It quickly became a trusted pathology software platform for specimen tracking, case management, and results reporting, developed at a time when laboratories were actively seeking to digitize their processes.
CoPath addressed several key challenges of that era:
Labeling and Specimen Tracking: Ensuring traceability from collection to diagnosis across the lab workflow.
Report Generation and Distribution: Producing pathology lab reports with accuracy and speed for clinicians and clients.
Data Storage and Pathology Lab Management: Organizing and retrieving patient and diagnostic information in a structured, accessible format.
CoPath's structured LIS lab database software and configurable design enabled laboratories to adapt workflows to their specific operational needs. Over time, hospitals and reference laboratories widely adopted CoPath as their primary LIS software platform, solidifying its reputation as a market leader.
CoPath’s Strengths and Limitations
A Strong Reputation That Began to Crack
CoPath's reputation as a stable and feature-rich laboratory information system software carried through the 2000s and into the 2010s. However, as healthcare regulations and technologies evolved, CoPath LIS began to reveal limitations that were difficult to address without a major overhaul.
Outdated Pathology LIS Technology Stack: Built on older programming languages and LIS software database structures, CoPath struggled to integrate with modern technologies, cloud systems, and APIs.
Lack of LIS System Automation and Scalability: Modern operations require faster processes through LIS lab automation and scalability, especially as testing volumes grow. CoPath's architecture was not optimized for these evolving needs.
Limited LIS System Interoperability: The rise of electronic health records and interoperability standards such as HL7 exposed significant gaps in CoPath's ability to connect seamlessly with external laboratory software systems.
User Interface Challenges: Laboratories sought modern, intuitive laboratory information systems, but CoPath's outdated interface hindered efficiency and diminished the user experience for both new and experienced staff
Despite ongoing updates from its parent companies, including Cerner Corporation, which later merged with Oracle, CoPath LIS struggled to adapt to the industry's changing needs fully.
The Turning Point: Cloud Adoption and AI Integration
How the Market Left Legacy LIS Systems Behind
In the mid-2010s, the pathology LIS market experienced a transformation driven by cloud computing, automation, and artificial intelligence. Forward-thinking laboratory information system companies began offering platforms that delivered real-time data insights and reporting, supported remote access and scalability via the cloud, integrated AI tools for enhanced diagnostics and laboratory workflow management optimization, and provided seamless laboratory billing and lab revenue cycle management (RCM) integrations.
CoPath, rooted in legacy LIS software architecture, faced mounting pressure from more agile lab vendors such as LigoLab, which built its LIS system methodology with modern technologies designed to support growth-minded labs.
Discover More: The Best Laboratory Information System Companies and the Advantages They Offer to Their Laboratory Clients
The End of the Road for CoPath LIS
A Declining Platform in a Rapidly Advancing Market
By the early 2020s, many labs had begun migrating away from CoPath’s lab information system in favor of medical LIS solutions designed to meet today's regulatory, technical, and operational demands. Oracle's acquisition of Cerner in 2022 further underscored this shift, as Oracle's focus moved toward larger enterprise systems, leaving many CoPath users uncertain about long-term support.
What Modern LIS Software Platforms Offer That CoPath Cannot
Today, CoPath is widely regarded as end-of-life LIS software. Labs transitioning from CoPath are increasingly moving to cloud-native LIS systems such as LigoLab's all-in-one medical LIS and lab billing platform, which emphasizes:
Automation and AI Integration: Reducing manual tasks and staffing needs while enabling predictive analytics across clinical and financial workflows.
Scalable Solutions: Supporting growth without requiring a complete overhaul of the laboratory information system as volume and complexity increase.
Interoperability: Seamlessly connecting with EHRs, laboratory revenue cycle management platforms, and diagnostic tools through modern interface standards.
Compliance and Security: Meeting modern regulatory requirements, including SOC 2, HIPAA, and CLIA standards, through embedded compliance verification and robust security infrastructure.
Discover More: A Detailed Look at How Modern Laboratory Information Systems Fully Support Quality Control
Key LIS Pathology Takeaways for Labs Moving Forward
The rise and decline of CoPath's LIS system offers valuable lessons for today's lab leaders:
Adopt Future-Proof LIS System Technology: Investing in a cloud-based LIS lab solution ensures adaptability to industry changes without the disruption of repeated platform overhauls.
Focus on Scalability: Select laboratory information system platforms that grow with your lab's operations and test volumes, without ceilings that force costly upgrades or transitions.
Prioritize Automation and AI: Modern laboratory information systems save time, reduce errors, and improve diagnostic accuracy by replacing manual processes with intelligent automation.
Evaluate Total Cost of Ownership: Legacy LIS systems often carry hidden costs for maintenance, upgrades, and downtime that far exceed the apparent savings of staying with an established platform.
Pathology labs that embrace new LIS medical technologies can reduce operational bottlenecks, improve efficiency, and enhance patient care, all while staying competitive in a rapidly evolving market.
Discover More: What to Look Out for and Avoid When Shopping for a New LIS System
Conclusion: A New Era for Pathology LIS Systems
While CoPath served laboratories well for decades, the demands of modern diagnostics have outgrown its capabilities. Today's laboratories require agile, automated, and highly connected pathology LIS systems that can support increasing workloads, evolving workflows, and intensifying competitive pressures. Modern laboratory information systems are driving this transformation, enabling laboratories to operate more efficiently, adapt more quickly, and scale with confidence.
For labs still running legacy laboratory information systems, now is the time to evaluate modern LIS lab options, ensuring the next chapter of the lab's journey is defined by growth and innovation backed by the best LIS software rather than outdated technology.
Industry Insights: Best LIS Systems - Top Laboratory Information Systems Compared for Clinical, Pathology, and Outreach Labs
Ready to Move Beyond Legacy LIS System Constraints?
Talk with a LigoLab product specialist and discover how a modern LIS lab solution can transform operations, eliminate bottlenecks, and open the door to sustainable growth and innovation.
Act Now: Schedule Your Personalized Consultation Today
Frequently Asked Questions About CoPath LIS and Transitioning to a Modern Laboratory Information System Software
What is CoPath LIS, and why is it sunsetting?
CoPath LIS is a legacy laboratory information system originally developed in the 1990s for anatomic pathology laboratories. Hospitals and reference labs widely adopted it as a trusted platform for specimen tracking, case management, and results reporting. However, its aging technology stack, built on older programming languages and database structures, has made it increasingly difficult to integrate with modern cloud infrastructure, AI tools, EHR systems, and interoperability standards. With Oracle's acquisition of Cerner accelerating the focus away from legacy systems, CoPath is now widely regarded as end-of-life software.
What were CoPath's biggest limitations that led to its decline?
CoPath's primary limitations included an outdated technology stack that struggled to integrate with modern APIs and cloud systems, insufficient automation and scalability for high-volume environments, limited interoperability with EHRs and HL7 standards, and a dated user interface that reduced efficiency and user satisfaction. These limitations became increasingly disqualifying as the industry shifted toward cloud-native, AI-integrated, and fully automated LIS platforms.
What should labs look for when selecting a CoPath LIS alternative?
Labs transitioning from CoPath should prioritize cloud-based deployment with flexible on-premise options, robust automation and rule engines, seamless EHR and instrument interoperability, integrated laboratory billing and lab revenue cycle management functionality, proven scalability without platform changes as volume grows, modern reporting and analytics capabilities, strong compliance support for HIPAA and CLIA, and a vendor with a demonstrated track record of post-implementation support and continuous platform development.
How does Oracle's acquisition of Cerner affect CoPath LIS users?
Oracle's acquisition of Cerner in 2022 shifted the parent company's strategic focus toward larger enterprise systems, leaving many CoPath users uncertain about the platform's long-term support, development roadmap, and update cadence. This shift has accelerated the migration of CoPath users toward modern, independently developed LIS platforms that prioritize laboratory-specific functionality and long-term innovation.
What are the hidden costs of staying on a legacy LIS system like CoPath?
The hidden costs of remaining on a legacy LIS system include increasing maintenance expenses, expensive and slow customization requests, downtime, and performance degradation as the system ages, manual workarounds that increase labor costs, poor integration with modern tools that limit revenue opportunities, and the eventual cost of an emergency transition when the platform reaches end-of-life without adequate planning time.
How does LigoLab's platform address the limitations that contributed to CoPath's decline?
LigoLab's all-in-one medical LIS and lab billing platform was built from the ground up with modern architecture, supporting cloud and on-premise deployment, seamless EHR and instrument integration via FHIR, HL7, and RESTful APIs, powerful rule and automation engines, integrated laboratory billing, AI-ready digital pathology workflows, and continuous platform updates. Unlike CoPath, LigoLab's tiered pricing model enables labs to scale to higher functionality levels without switching systems, eliminating the disruption CoPath users are facing.
How should a lab plan its transition away from CoPath or another sunsetting LIS system?
A well-managed LIS system transition typically begins 12 to 18 months before the planned go-live date. Labs should start by forming a selection committee, defining non-negotiable system requirements, conducting market research using resources such as the CAP Today LIS Product Guide, issuing a Request for Proposal to shortlisted vendors, evaluating responses, conducting live demonstrations, checking references, arranging site visits, finalizing vendor selection, and then working backward from the desired go-live date to establish a realistic implementation timeline.
